Genxone Spolka Akcyjna Logo

Genxone Spolka Akcyjna

A biotechnology company specializing in Next Generation Sequencing and medical diagnostics.

GX1 | WAR

Overview

Corporate Details

ISIN(s):
PLGENXN00013
LEI:
25940043REFNZY18T558
Country:
Poland
Address:
SUCHY LAS ZŁOTNIKI, KOBALTOWA 6, 62-002 SUCHY LAS

Description

Genxone is a biotechnology company that develops products and solutions based on advanced nucleic acid technologies. The company specializes in Next Generation Sequencing (NGS) and medical diagnostics, offering a range of DNA and RNA sequencing services. It is a pioneer in the application of nanopore sequencing technology, developed by Oxford Nanopore Technologies, being one of the first laboratories globally to utilize it for commercial applications in science, business, and medicine. Key services include whole-genome sequencing, metagenomic sequencing, 16S/ITS gene sequencing, custom-designed analyses, and comprehensive bioinformatic support.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-08 14:25
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.2 KB
2024-03-06 16:41
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.8 KB
2023-11-16 15:32
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 1.1 KB
2023-11-14 14:32
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.7 KB
2023-10-23 16:34
Aktualizacja informacji na temat umowy warunkowej o istotnym znaczeniu - Conten…
Polish 948 bytes
2023-07-20 15:09
Zawarcie istotnej umowy - Content (PL)
Polish 1.0 KB
2023-06-19 15:31
Lista akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 470 bytes
2023-05-22 15:37
Sprawozdanie RN genXone za 2022 rok
Polish 991.6 KB
2023-05-22 15:37
Projekty uchwał WZA genXone SA
Polish 284.6 KB
2023-05-22 15:37
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone SA
Polish 291.5 KB
2023-05-22 15:37
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Spółki genXone S.A. na d…
Polish 6.6 KB
2023-05-09 15:57
Podpisanie umowy warunkowej o istotnym znaczeniu - Content (PL)
Polish 857 bytes
2023-05-05 16:54
Informacja o wyborze najkorzystniejszej oferty - Content (PL)
Polish 1.5 KB
2023-04-26 17:03
Aktualizacja informacji na temat prac badawczych w ramach projektu NANOBIOME - …
Polish 1.7 KB
2023-03-21 08:05
Zawiadomienia_o_transakcjach_osoby_zobowiazanej_Jakub_Swadzba_20230320.pdf
Polish 9.7 KB

Automate Your Workflow. Get a real-time feed of all Genxone Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genxone Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genxone Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.